Peer-reviewedLicence not statedCEN Case Reports
Ravulizumab monotherapy for anti-CFH antibody-associated aHUS in an elderly patient: a case report highlighting individualized clinical decision-making
- 1National Hospital Organization Kumamoto Medical Center, 1-5 Ninomaru, Kumamoto, Kumamoto Japan
- 2Kumamoto University Hospital, 1-1-1 Honjo, Kumamoto, Kumamoto Japan
Related
- Pregabalin Monotherapy for Chronic Pain Associated with Osteoarthritis in Working Dogs: A Retrospective Study of 21 Cases
- Individualized statin associated type 2 diabetes risk estimation with a deep causal model
- Antibody-opsonized extracellular traps modulate macrophage responses and attenuate their T cell-associated inflammatory and costimulatory characteristics
- 749 Reprogramming of macrophage Fc receptor expression and antibody handling by cachexia-associated tumor secretory factors
- Ravulizumab in neuromyelitis optica spectrum disorder: first clinical experience in Chile
BibTeX
@article{yoshii2026ravulizumab,
title = {{Ravulizumab monotherapy for anti-CFH antibody-associated aHUS in an elderly patient: a case report highlighting individualized clinical decision-making}},
author = {Ryuichi Yoshii and Kengo Kajiwara and Keitaro Hirose and Toshiki Hatanaka and Akiko Shimasaki and Masao Tomita and Hideki Yokoi},
journal = {CEN Case Reports},
year = {2026},
month = oct,
doi = {10.1007/s13730-026-01200-8},
url = {https://doi.org/10.1007/s13730-026-01200-8},
}
RIS
TY - JOUR
TI - Ravulizumab monotherapy for anti-CFH antibody-associated aHUS in an elderly patient: a case report highlighting individualized clinical decision-making
AU - Ryuichi Yoshii
AU - Kengo Kajiwara
AU - Keitaro Hirose
AU - Toshiki Hatanaka
AU - Akiko Shimasaki
AU - Masao Tomita
AU - Hideki Yokoi
PY - 2026
DA - 2026/10/27
JO - CEN Case Reports
DO - 10.1007/s13730-026-01200-8
UR - https://doi.org/10.1007/s13730-026-01200-8
SN - 2192-4449
ER -